These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23228630)

  • 1. [Contrast-enhanced ultrasonography in the diagnosis of hepatocellular carcinoma].
    Forner A; Bruix J
    Radiologia; 2013; 55(2):173-4. PubMed ID: 23228630
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
    Maruyama K; Yoshikawa M; Yokosuka O
    JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced intraoperative ultrasonography: a valuable and not any more monocentric diagnostic technique performed in different ways.
    Torzilli G; Del Fabbro D; Palmisano A; Donadon M; Montorsi M
    Ann Surg; 2007 Jan; 245(1):152-3; author reply 152-3. PubMed ID: 17197980
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and liver metastases.
    Seitz K
    Ultraschall Med; 2005 Aug; 26(4):267-9. PubMed ID: 16123919
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis.
    Kee KM; Lu SN
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):277-279. PubMed ID: 28162003
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of hepatocellular carcinoma by contrast enhanced ultrasound: a novel technique.
    Paul SB; Jaganathan S; Hasan A; Dhingra R; Gamanagatti SR; Gupta AK; Acharya SK
    Trop Gastroenterol; 2010; 31(3):213-6. PubMed ID: 21560527
    [No Abstract]   [Full Text] [Related]  

  • 7. Education and Imaging. Hepatobiliary and pancreatic: spontaneous regression of hepatocellular cancer demonstrated by contrast-enhanced ultrasonography.
    Nishijima N; Marusawa H; Kita R; Osaki Y; Chiba T
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1153. PubMed ID: 19638097
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound has come of age.
    Albrecht T
    Ultraschall Med; 2008 Sep; 29 Suppl 4():S187. PubMed ID: 18833496
    [No Abstract]   [Full Text] [Related]  

  • 9. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study.
    Boozari B; Soudah B; Rifai K; Schneidewind S; Vogel A; Hecker H; Hahn A; Schlue J; Dietrich CF; Bahr MJ; Kubicka S; Manns MP; Gebel M
    Dig Liver Dis; 2011 Jun; 43(6):484-90. PubMed ID: 21377941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
    Barreiros AP; Piscaglia F; Dietrich CF
    J Hepatol; 2012 Oct; 57(4):930-2. PubMed ID: 22739095
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis.
    Dănilă M; Sporea I; Sirli R; Popescu A; Sendroiu M; Martie A
    Med Ultrason; 2010 Jun; 12(2):145-9. PubMed ID: 21173943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnosis of the early stage of hepatocellular carcinoma by US-angiography with intraarterial Albunex (sonicated serum albumin) infusion].
    Ono N; Ijuin H; Ono N; Tateishi Y; Ogata R; Kuromatsu R; Itano S; Sata M; Tanikawa K
    Nihon Rinsho; 1998 Apr; 56(4):956-60. PubMed ID: 9577616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
    AJR Am J Roentgenol; 2004 May; 182(5):1224-6. PubMed ID: 15100123
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast-enhanced sonography for hepatocellular carcinoma.
    Choi BI; Lee JY; Han JK; Lee JM; Kim SH
    Intervirology; 2004; 47(3-5):162-8. PubMed ID: 15383725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.
    Kudo M; Hatanaka K; Kumada T; Toyoda H; Tada T
    Am J Gastroenterol; 2011 Feb; 106(2):368-70. PubMed ID: 21301463
    [No Abstract]   [Full Text] [Related]  

  • 17. [EFSUMB-guidelines for CEUS are directive and effective].
    Seitz K
    Ultraschall Med; 2010 Jun; 31(3):225-7. PubMed ID: 20517814
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity rates in characterizing hepatocellular carcinomas.
    Caturelli E; Ghittoni G; Roselli P; Anti M
    AJR Am J Roentgenol; 2005 Oct; 185(4):1079-80; author reply 1080-1. PubMed ID: 16177438
    [No Abstract]   [Full Text] [Related]  

  • 19. Best cases from the AFIP: fibrolamellar hepatocellular carcinoma.
    Smith MT; Blatt ER; Jedlicka P; Strain JD; Fenton LZ
    Radiographics; 2008; 28(2):609-13. PubMed ID: 18349461
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of enhanced US by CO2 microbubbles for segmental-subsegmental TAE for hepatocellular carcinoma].
    Ohno K; Fujita M; Nakamura T; Sato O; Maeda T
    Nihon Rinsho; 1998 Apr; 56(4):994-1000. PubMed ID: 9577623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.